Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery
Sponsor: Nantes University Hospital
Summary
Postoperative complications are major healthcare problems and are associated with a reduced short-term and long-term survival after surgery. Major surgery is associated with a predictable and usually transient Systemic Inflammatory Response (SIRS), depending on the magnitude of the surgical trauma. An excessive SIRS syndrome participates to the development of postoperative organ dysfunction, infection and mortality. Corticosteroids may decrease the postsurgical SIRS in cardiac surgery: in a large multicenter randomized trial, a single intravenous administration of high-dose dexamethasone did not reduce the incidence of a composite endpoint of adverse events but was associated with a reduced incidence of postoperative pulmonary complications and infections and with a reduction in hospital stay. However, a similar study, recently published in the Lancet was negative. Evidences from one meta-analysis, including 11 studies of moderate quality (439 patients in total), suggest that intraoperative administration of corticosteroids during major abdominal surgery decreases postoperative complications, including infectious complications, without significant risk of anastomotic leakage. At present, no large randomized controlled trial has been performed in patients undergoing major non-cardiac surgery. In acute medicine, several lines of evidence have shown that low to moderate doses of corticosteroids decrease the excessive inflammatory response, without inducing immuno suppression. However, despite the widespread use of corticosteroids to reduce postoperative nausea and vomiting and to improve analgesia, concerns continue to be raised about their safety, especially regarding an increased risk of postoperative infection. We hypothesize that the perioperative administration of glucocorticoids would reduce postoperative morbidity after major non-cardiac surgery through dampening of the inflammatory response. Given the number of surgical patients for whom the question applies, the study is of significant clinical importance
Official title: Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery : a Randomized, Multicentre, Double Blind, Study
Key Details
Gender
All
Age Range
50 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
1222
Start Date
2017-12-13
Completion Date
2019-04-16
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
Dexamethasone
Dexamethasone : first dose : 0,2mg.kg-1 at the end of the surgical procedure, second dose (0,2 mg.kg-1) 24 hours after the surgery
Placebos
placebo : first infusion at the end of the surgical procedure, second 24 hours after the surgery
Locations (29)
CHU Angers
Angers, France
CHU La Cavale Blanche
Brest, France
Hôpital Estaing, CHU de Clermont Ferrand
Clermont-Ferrand, France
Hôpital Beaujon
Clichy, France
CHD Vendée
La Roche-sur-Yon, France
Centre Hospitalier Du Mans
Le Mans, France
Hôpital Claude Huriez
Lille, France
Hopital Edouard Herriot
Lyon, France
Institut Paoli Calmettes
Marseille, France
Hôpital Timone
Marseille, France
Hôpital Nord
Marseille, France
Hôpital Saint-Eloi
Montpellier, France
Clinique Jules Verne
Nantes, France
Le Confluent
Nantes, France
Hotel Dieu Nantes
Nantes, France
Hôpital Laennec
Nantes, France
C.R.L.C.C. Nantes Atlantique
Nantes, France
Hôpital Saint Antoine
Paris, France
Hôpitaux Universitaires Saint-Louis, Lariboisière, Fernand Widal
Paris, France
CHU Lyon Sud
Pierre-Bénite, France
CHU de Poitiers
Poitiers, France
Ch Quimper
Quimper, France
Hôpital Pontchaillou
Rennes, France
CHU de Rouen
Rouen, France
CHU Saint Etienne
Saint-Etienne, France
Nouvel Hôpital Civil
Strasbourg, France
CHU de Toulouse
Toulouse, France
CH Valenciennes
Valenciennes, France
Institut Gustave Roussy
Villejuif, France